4 results about "Amine alkylation" patented technology

The invention discloses a synthesis method of Olrabatinib, which comprises the following steps: by taking 2-methyl-5-nitro trifluorotoluene as a raw material, carrying out a Waller-Ziegler reaction, an alkylation / silanization reaction of amine, nitro reduction, a condensation reaction and a Caslow-Stevens coupling reaction, so as to obtain the Olrabatinib. By optimizing process conditions and a reaction system, the synthesis method disclosed by the invention has the remarkable advantages in the following aspects: the raw material cost is greatly reduced by adopting low solvent consumption; the product yield is improved by accurately controlling reaction parameters; a standardized post-treatment process is developed, and large-scale stable production is realized. According to the technical system, the technical bottlenecks of high energy consumption and high pollution in the traditional synthesis route are effectively solved, and an innovative solution is provided for green manufacturing of fine chemicals.

The invention discloses a catalyst for aniline alkylation and a preparation method, and belongs to the technical field of catalysts. The preparation method of the catalyst comprises the following steps: roasting a catalyst carrier precursor, and adding desalted water into a roasted product to prepare slurry; preparing a mixed solution of copper salt, zinc salt and chromium salt; additionally preparing an alkali solution; adding a metal salt mixed solution and an alkaline solution into the slurry, carrying out a co-precipitation reaction, and then aging; repeatedly filtering and pulping the aged slurry to obtain a catalyst precipitation filter cake; and drying, forming and calcining to obtain the catalyst. The invention also discloses the catalyst for aniline alkylation, which is prepared by the method. The catalyst provided by the invention can realize concerted catalysis of aniline alkylation and methanol steam cracking in a single reactor, methanol and aniline are taken as raw materials, N-methylaniline is synthesized with high selectivity, high-purity hydrogen is co-produced, and no wastewater is discharged in the reaction process.

This invention belongs to the field of pharmaceutical synthesis technology, specifically disclosing an aminoalkylated paeonol chalcone derivative, its preparation method, and its pharmaceutical uses. The aminoalkylated paeonol chalcone derivative of this invention is shown in general formula (I). It is obtained by using paeonol as a raw material, linking the phenolic hydroxyl groups on paeonol to organic amine fragments using different linking arms, and then performing Claisen-Schmidt condensation with various benzaldehydes. In vitro antitumor experiments have demonstrated that the derivative of this invention exhibits good antitumor activity against human colon cancer cells (HCT116), human liver cancer cells (HepG2), human lung cancer cells (A549), and human osteosarcoma cells (U2OS), and has significantly better water solubility than paeonol chalcone. It holds promise for development as a therapeutic drug for various cancers such as colon cancer, osteosarcoma, lung cancer, and liver cancer, with broad clinical application prospects.

The application discloses application of a supported Ni-Cu catalyst in alcohol amine alkylation reaction, wherein the alcohol is a fatty alcohol, and the amine is an organic amine, and the alcohol amine alkylation reaction is carried out under the action of the supported Ni-Cu catalyst. The application can reduce the production cost of the catalyst, reduce the energy consumption of the alcohol amine alkylation reaction, and inhibit the side reaction caused by the breakage of C-N bonds in the raw material amine.